NCT02391870

Brief Summary

Pregnant women with histories of depression are at high risk of depressive relapse during the perinatal period, and options for relapse prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at risk pregnant women. This study is the first phase of a multi-phase project adapting MBCT for perinatal women (MBCT-PD). It is being conducted in a collaboration between the University of Colorado, Emory University, and Kaiser Permanente at Colorado and Georgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Nov 2008

Typical duration for not_applicable pregnancy

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 18, 2015

Completed
Last Updated

April 6, 2020

Status Verified

April 1, 2020

Enrollment Period

2.3 years

First QC Date

March 12, 2015

Last Update Submit

April 2, 2020

Conditions

Keywords

depressionmindfulnesspregnancypreventioncognitive behavioral therapy

Outcome Measures

Primary Outcomes (5)

  • Engagement

    Engagement is operationalized in-part as class attendance, with completion is defined as attendance at a minimum of four classes, and daily home practice recorded daily as the number of times of practice and type of practice, which are classified as either formal or informal practice.

    Up to 8 weeks

  • Client Satisfaction

    Participant satisfaction will be evaluated by the CSQ-8, which is designed to yield a homogeneous estimate of general satisfaction with services. An exit interview also will be completed at 6-months postpartum.

    Up to 8 weeks

  • MBCT-PD Adherence Scale (MBCT-PD-AS)

    Treatment fidelity will be assessed to provide checks on the adequacy of treatment implementation, using the MBCT-PD Adherence Scale.

    Up to 8 weeks

  • Depressive Relapse Status: Longitudinal Interval Follow-up Evaluation (LIFE)

    Rate of depressive relapse and time to relapse will be assessed using the LIFE, which provides a retrospective assessment of relapse or recurrence based on a semi-structured interview according to DSM-IV-TR diagnostic criteria.

    Up to 6 months postpartum

  • Change in Edinburgh Postpartum Depression Scale (EPDS)

    Change in the severity of depressive symptoms will be evaluated by the Edinburgh Postpartum Depression Scale (EPDS), which is the most widely used self-report measure of antenatal and postpartum depression.

    Up to 6 months postpartum

Study Arms (1)

MBCT-PD

EXPERIMENTAL

Mindfulness-based cognitive therapy adapted for perinatal women (MBCT-PD)

Behavioral: MBCT-PD

Interventions

MBCT-PDBEHAVIORAL

Using an iterative process, the investigators modified MBCT to include a focus on perinatal depression (MBCT-PD). The modifications took into account developmental processes associated with the perinatal period, characteristics and correlates of perinatal depression, and the physical aspects of pregnancy.

MBCT-PD

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant up to 32 weeks gestation
  • Meeting criteria for prior depression
  • Failure to meet criteria for a diagnosis of MDD in the last two months
  • Available for group intervention scheduled meetings

You may not qualify if:

  • Presence of schizophrenia or schizoaffective disorder
  • Presence of bipolar disorder or current psychosis
  • Presence of organic mental disorder or pervasive developmental delay
  • Presence of current eating disorder
  • Presence of current substance abuse or dependence
  • Presence of antisocial, borderline, or schizotypal personality disorder
  • Presence of imminent suicide or homicide risk
  • Presence of any other axis I or II disorders that necessitate priority treatment not provided by the study protocol
  • Women with any medical conditions that would preclude participation, including high-risk pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of Colorado Boulder

Boulder, Colorado, 80309, United States

Location

Kaiser Permanente Colorado

Denver, Colorado, 80234, United States

Location

Emory University

Atlanta, Georgia, 30322, United States

Location

Kaiser Permanente

Atlanta, Georgia, 30328, United States

Location

MeSH Terms

Conditions

DepressionDepression, Postpartum

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPuerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Sona Dimidjian, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR
  • Sherryl Goodman, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Director

Study Record Dates

First Submitted

March 12, 2015

First Posted

March 18, 2015

Study Start

November 1, 2008

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

April 6, 2020

Record last verified: 2020-04

Locations